XML 67 R45.htm IDEA: XBRL DOCUMENT v3.25.1
SHARE CAPITAL (Tables)
 12 Months Ended
Dec. 31, 2024
IfrsStatementLineItems [Line Items]  
SCHEDULE OF CALCULATION OF LOSS ON EXTINGUISHMENT

 

Calculation of loss on extinguishment:     
New cash proceeds  $105,000 
Carrying amount of the extinguished warrant liability  $312,983 
Consideration Received  $417,983 
      
Consideration Given     
New warrant liability (672,000; exercise price of $3.18)  $626,482 
Preferred share liability (118 shares)  $138,824 
Common shares (152,000 @ $1.67 per share)  $253,840 
Consideration Given  $1,019,146 
      
Loss on extinguishment  $601,163 
SCHEDULE OF STOCK OPTION ACTIVITY BASED ON GRANT DATE

A summary of the Company’s stock option activity is as follows:

 

Grant Date  Number of options outstanding   Number of options exercisable   Weighted Average Exercise Price   Expiry date  Remaining contractual
life (years)		 
                    
15-Nov-20   1    1    756,000.00   15-Nov-30   5.88 
15-Nov-20   1    1    756,000.00   15-Nov-25   0.87 
13-Apr-22   6    6    138,600.00   13-Apr-27   2.28 
12-Jul-22   3    2    138,600.00   12-Jul-25   0.53 
 Total   11    10   $250,854.55       2.00 
SCHEDULE OF STOCK OPTIONS

 

   Number of Stock   Weighted Average 
   Options   Exercise Price 
Outstanding options, December 31, 2022   13   $46,376.16 
Expired/Cancelled   (1)   162,684.00 
Outstanding options, December 31, 2023   12   $38,903.00 
Expired/Cancelled   (1)   2,268.44 
Outstanding options, December 31, 2024   11   $250,854.55 
SCHEDULE OF RESTRICTED SHARE UNIT ACTIVITY BY GRANT DATE

A summary of the Company’s restricted share unit activity during the year ended December 31, 2023 and the year ended December 31, 2024 is as follows: 

 

Grant Date  Number of RSU’s outstanding   Number of RSU’s exercisable   Weighted Average Issue Price 
9-Mar-22   17    17    129,780.00 
13-Apr-22   7    7    138,600.00 
                
Outstanding RSU, December 31, 2024   24    24   $132,352.50 
SCHEDULE OF RESTRICTED SHARE UNITS ACTIVITY

 

   Number of RSU’s  

Weighted Average

Issue Price

 
Outstanding RSU, December 31, 2022   25   $132,325.20 
Exercised/cancelled   (1)   (138,600.00)
Outstanding RSU, December 31, 2023   24   $132,352.50 
Exercised/cancelled   -    - 
Outstanding RSU, December 31, 2024   24   $132,352.50 
SCHEDULE OF SHARE PURCHASE WARRANT ACTIVITY BY GRANT DATE

A summary of the Company’s share purchase warrant activity is as follows: 

 

Grant Date  Number of Warrants outstanding and exercisable   Exercise Price   Expiry date
29-Sep-20   14    863,100.00   28-Sep-25
11-Jan-22   80    289,800.00   10-Jan-27
31-Oct-23   56    12.60   none
Total   150   $235,120.70    
SCHEDULE OF SHARE PURCHASE WARRANT

   Number of Warrants   Weighted average exercise price 
Outstanding, December 31, 2022   271   $272,258.22 
Granted   564   $7,001.78 
Expired   (10)   (1,449,000)
Exercised   (525)  $52,272.00 
Outstanding, December 31, 2023   310   $162,219.95 
Granted   300,681   $1,231.33 
Expired   (10)   (1,449,000)
Exercised/Exchanged   (300,831)  $640.06 
Outstanding, December 31, 2024   150   $235,120.70 
Agent options [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF STOCK OPTION ACTIVITY BASED ON GRANT DATE

A summary of the Company’s agent options activity is as follows: 

 

Grant Date  Number of options outstanding   Number of options exercisable   Weighted Average Exercise Price   Expiry date  Remaining contractual life (years) 
29-Sep-20   1    1   $831,600.00   28-Sep-25   0.74 
29-Sep-20   2    2   $863,100.00   28-Sep-25   0.74 
11-Jan-22   3    3   $318,780.00   11-Jan-27   2.03 
31-Oct-23   95    95   $900.90   31-Oct-28   3.84 
Total Agent options   101    101    35,640.85       3.69 
SCHEDULE OF STOCK OPTIONS

   Number of   Weighted average 
   options   exercise price 
Outstanding agent options, December 31, 2021   4   $94,626.00 
Granted   4    31,626.00 
Expired   (2)   144,900.00 
Outstanding agent options, December 31, 2022   8   $63,126.00 
Granted   95    90.09 
Outstanding agent options, December 31, 2023   103   $4,986.08 
Expired   (2)   144,900.00 
Outstanding agent options, December 31, 2024 and the date of the MD&A   101    35,640.85